本頁面由Tiger Trade Technology Pte. Ltd.提供服務

F-star Therapeutics, Inc.

7.12
0.0000
成交量:- -
成交額:- -
市值:1.57億
市盈率:-3.39
高:7.12
開:7.12
低:7.12
收:7.12
52周最高:7.12
52周最低:7.12
股本:2,198.19萬
流通股本:2,129.46萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.1005
每股收益(LYR):-1.8791
淨資產收益率:-60.87%
總資產收益率:-21.63%
市淨率:2.75
市盈率(LYR):-3.79

資料載入中...

2021/04/14

重要事件披露

8-K - Current report
2021/04/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/07

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/05

重要事件披露

8-K - Current report
2021/04/05

重要事件披露

8-K - Current report
2021/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/29

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

重要事件披露

8-K/A [Amend] - Current report
2021/02/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/25

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/01/04

重要事件披露

8-K - Current report
2020/12/04

重要事件披露

8-K - Current report
2020/12/03

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/11/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/30

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals